TMCI
Treace Medical Concepts, Inc. Common Stock
stockNASDAQ
treace medical concepts, inc. is a privately-funded, commercial stage company focused on bringing breakthrough technologies to the high-growth $1.1 billion us market for foot and ankle surgical products. we are committed to operating our business with the highest standards of ethical conduct. we will exceed our customers' expectations through an innovation-driven, high-velocity approach to solving treatment and surgical problems. with our products and services, our mission is to assist foot and ankle physicians in improving patient outcomes and reducing healthcare costs, while providing a rewarding experience for our employees and an exceptional return for our shareholders.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 4.48 | 2026-09-28 | -2.01% | 1.801 |
| 1M | 4.81 | 2026-09-04 | -8.73% | 1.121 |
| 3M | 4.56 | 2026-07-06 | -3.73% | 1.689 |
| 6M | 1.44 | 2026-04-06 | +204.86% | 1.115 |
| 1Y | 6.36 | 2025-10-03 | -30.98% | 1.577 |
| 2Y | 5.34 | 2024-10-04 | -17.79% | — |
| 5Y | 25.09 | 2021-10-04 | -82.50% | 1.336 |
Treace Medical Concepts, Inc. Common Stock (NASDAQ:TMCI) stock price today is $4.39, and today's volume is 154,671. TMCI is up 1.386% today. The 30 day average volume is 238,133. TMCI market cap is $285.50M with 65.03M shares outstanding.